v3.26.1
INDEMNIFIED AND REPURCHASED LOANS (Tables)
6 Months Ended
Jun. 30, 2026
INDEMNIFIED AND REPURCHASED LOANS  
Schedule of indemnified and repurchased loans and their location

​

​

​

​

​

​

​

Other Assets and Other Liabilities Related to Indemnified and Repurchased Loans (in thousands)

June 30, 2026

  ​ ​ ​

December 31, 2025

Other Assets

​

​

​

​

​

Indemnified loans

$

91,439

​

$

46,253

Repurchased loans

 

44,678

​

 

36,926

Allowance for loan losses

 

(39,635)

​

 

(5,410)

Loans held for investment, net - indemnified and repurchased loans

$

96,482

​

$

77,769

​

​

​

​

​

​

Other assets, gross (1)(2)(3)

$

50,380

​

$

50,380

Impairment(2)(3)

​

(14,702)

​

​

(11,500)

Other assets, net(3)

$

35,678

​

$

38,880

Total other assets

$

132,160

​

$

116,649

​

​

​

​

​

​

Other Liabilities

​

​

​

​

​

Secured borrowings

$

133,055

​

$

83,402

Indemnification reserves (4)

​

7,961

​

​

23,920

Total other liabilities

$

141,016

​

$

107,322

(1)Comprised of Other real estate owned (“OREO”) and an Other asset as described in NOTE 2 of the Company’s 2025 Form 10-K.
(2)The OREO asset and the other asset, net were held for sale as of June 30, 2026. Upon reclassification from held for use to held for sale in the first quarter of 2026, the Company recorded an impairment charge of $1.5 million as seen in the table below. The fair value for both the OREO asset and the other asset, net was determined by appraisal. OREO and other asset, net are presented as components of Other assets on the Condensed Consolidated Balance Sheets.
(3)These real estate assets were held for sale as of June 30, 2026 and held for use as of December 31, 2025.
(4)NOTE 2 in the 2025 Form 10-K contains information about the nature of these reserves.
Schedule of maximum expected future payments

​

​

​

​

​

​

​

Maximum Expected Future Payments (in thousands)

June 30, 2026

  ​ ​ ​

December 31, 2025

Secured borrowings

$

133,055

​

$

83,402

Collateral for secured borrowings (1)

​

(50,578)

​

​

(22,668)

Total

$

82,477

​

$

60,734

(1)The Company has funded this balance with corporate cash into an escrow account held by the GSE to collateralize the secured borrowing. The collateral is included in Receivables, net on the Condensed Consolidated Balance Sheets.
Schedule of allowance for loan losses related to indemnified and repurchased loans

​

​

​

​

​

​

​

​

​

​

​

​

​

​

As of and for the three months ended

​

As of and for the six months ended

Roll Forward of Allowance for Loan Losses
(in thousands)

June 30, 2026

  ​ ​ ​

June 30, 2025

​

June 30, 2026

  ​ ​ ​

June 30, 2025

Beginning balance

$

29,077

​

$

4,060

​

$

5,410

​

$

4,060

Provision (benefit) for loan losses

​

10,558

​

​

500

​

​

13,058

​

​

500

Transfers from purchased credit deteriorated initial allowance

​

—

​

​

—

​

​

21,167

​

​

—

Write-offs

 

—

​

 

—

​

 

—

​

 

—

Ending balance

$

39,635

​

$

4,560

​

$

39,635

​

$

4,560

Schedule of indemnified and repurchased loan expenses

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the three months ended

​

For the six months ended

Impact of Indemnified and Repurchased Loans (in thousands)

June 30, 2026

  ​ ​ ​

June 30, 2025

​

June 30, 2026

  ​ ​ ​

June 30, 2025

Initial loan repurchase costs

$

—

​

$

—

​

$

797

​

$

322

Indemnified and repurchased loan operating costs

​

5,220

​

​

683

​

​

7,534

​

​

1,218

Expected principal losses on loan repurchase ("loan repurchase losses")

 

1,664

​

 

—

​

 

8,614

​

 

—

Indemnified and repurchased loan expenses

$

6,884

​

$

683

​

$

16,945

​

$

1,540

​

​

​

​

​

​

​

​

​

​

​

​

Other Activity Related to Indemnified and Repurchased Loans

​

​

​

​

​

​

​

​

​

​

​

Provision (benefit) for loan losses(1)

​

10,558

​

​

500

​

​

13,058

​

​

500

Provision (benefit) for risk sharing obligations (1)(2)

​

5,752

​

​

—

​

​

5,752

​

​

—

Other operating expenses (3)

​

—

​

​

—

​

​

1,538

​

​

—

Other interest income (4)

​

(467)

​

​

—

​

​

(1,541)

​

​

—

Total net expense impact of indemnified and repurchased loans

$

22,727

​

$

1,183

​

$

35,752

​

$

2,040

(1)Included as a component of Provision (benefit) for credit losses in the Condensed Consolidated Statements of Income.
(2)Impact on Provision (benefit) for risk-sharing obligations resulting from modified loss sharing in lieu of repurchase on $15.9 million of defaulted loans.
(3)Includes impairment charges related to the OREO asset that was previously repurchased and included as a component of Other operating expenses in the Condensed Consolidated Statements of Income.
(4)Included as a component of Placement fees and other interest income in the Condensed Consolidated Statements of Income.
Schedule of portion of the indemnified and repurchased loans on nonaccrual status

​

​

​

​

​

​

​

Non-accrual loans (in thousands)

June 30, 2026

  ​ ​ ​

December 31, 2025

Loans held for investment UPB

$

139,903

​

$

48,630

Cost basis and fair value adjustments, net

​

(7,108)

​

​

1,331

Allowance for loan losses

​

(39,635)

​

​

(5,410)

Non-accrual loans, net

$

93,160

​

$

44,551

​